Skip to content
MarketScale
‹ Back to IndustriesHealthcare

DESIGN TRANSFER: A PROCESS NOT A SINGULAR EVENT

In the development process for medical devices, there comes a point when products transfer from design to production. Often this step doesn’t go as smoothly as it should and the project budget and schedule are adversely impacted. Companies may view design transfer as a one-time event, rather than an essential part of an ongoing process….

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

In the development process for medical devices, there comes a point when products transfer from design to production. Often this step doesn’t go as smoothly as it should and the project budget and schedule are adversely impacted. Companies may view design transfer as a one-time event, rather than an essential part of an ongoing process.

During the product development process, the Research and Development (R&D) team is under a tight deadline. They may not have the necessary resources or take sufficient time to create proper documentation. Team members may need to make decisions quickly without fully considering how they could take proactive steps to ensure design transfer will go more smoothly. Subject matter experts on the team may only focus on critical design decisions required to make the product work, without regard for manufacturing. Let’s take a look at some ways to improve design transfer.

Look at Design Transfer as a Process Rather than a Single Event

Design transfer is an integral part of the product development process, from conception through final manufacture. Highly reliable, cost-efficient medical devices require proper design transfer, and that starts with Design for Manufacturability (DFM) and Design for Manufacturing and Assembly (DFMA). In DFM and DFMA the focus is not only on the design itself, but also on the assembly method, ensuring manufacturing readiness for building Beta units, pre-production clinical units, and the pilot program. When the R&D team considers these factors and performs in-process testing, it can significantly improve product quality and reduce the overall cost of manufacturing.

Using DFMA 

The goal of DFMA is simple: to transfer product design into viable, robust production methods. To succeed, the team must establish and maintain procedures that ensure the device design translates into production specifications, including final test acceptance. The transfer should negate and/or identify remaining risks such as single-sourcing, long lead items, build timelines, and line/tooling capacity.

A Design Ready for Transfer:

  • Can be built reliably using known and proven manufacturing and assembly processes
  • Includes supporting cell/line qualifications through manufacturing validations such as Operational Qualification (OQ) and Performance Qualification (PQ)
  • Specifies and documents any inspection aids, assembly fixtures, and custom tools required for manufacture
  • Confirms completed agency testing and production target hardware meets regulatory requirements such as FDA, UL, and CE
  • Includes a complete product Bill of Material (BOM) that has been fully costed up to the customer Stock Keeping Unit (SKU) level
  • Includes packaging, labeling, and Instructions for Use (IFU)

At Sunrise Labs, we see Design Transfer as an integral process beginning early in the life of a product with many crucial steps for success. Communication between key stakeholders early and often is critical to turn innovative ideas into commercial medical devices.

Read more at sunriselabs.com

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

ONC marks universal EHR adoption and one billion TEFCA health records exchanged in inaugural Coordinator's Quarterly

ONC marks universal EHR adoption and one billion TEFCA health records exchanged in inaugural Coordinator's Quarterly

The Office of the National Coordinator for Health Information Technology (ONC) has announced universal adoption of Electronic Health Records (EHR) across U.S. healthcare. Additionally, the Trusted Exchange Framework and Common Agreement (TEFCA) has facilitated the exchange of one billion health records. These milestones emphasize the significant progress in digital health record interoperability in the United States.

  • 01Universal adoption of Electronic Health Records (EHR) has been achieved across the U.S. healthcare system.
  • 02TEFCA has successfully facilitated the exchange of one billion health records.
  • 03These developments mark significant progress in the interoperability of digital health records.

Jul 23, 2026

OpenEvidence expands clinical AI across NewYork-Presbyterian, Columbia, and Weill Cornell as Linux Foundation targets open-source health stack

OpenEvidence expands clinical AI across NewYork-Presbyterian, Columbia, and Weill Cornell as Linux Foundation targets open-source health stack

OpenEvidence is expanding its clinical AI technologies across major New York healthcare institutions including NewYork-Presbyterian, Columbia, and Weill Cornell. Concurrently, the Linux Foundation is establishing efforts to create an open-source health technology stack. Delaware is expanding its Health Information Exchange (HIE) access.

  • 01OpenEvidence expands clinical AI deployment in prominent New York-based healthcare facilities.
  • 02The Linux Foundation is developing an open-source stack for healthcare technology.
  • 03Delaware is enhancing access to its Health Information Exchange (HIE).

Jul 22, 2026

AI agents for patient care draw $335 million in a single month as health tech investment accelerates

AI agents for patient care draw $335 million in a single month as health tech investment accelerates

In June 2026, four health tech companies secured significant funding, totaling $335 million. AI agent platforms for scheduling, chronic care, and home health dominated these investment rounds. This trend reflects a growing interest in leveraging AI for improving patient care in the healthcare sector.

  • 01In June 2026, four health tech companies collectively attracted $335 million in funding.
  • 02AI platforms for chronic care management, scheduling, and home health are leading current health tech investments.
  • 03Investors are increasingly interested in AI technologies that enhance patient care in healthcare.

Jul 20, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512